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Introduction. Primary venous tumours are a rare cause of deep vein thrombosis. The authors present a case where the deﬁnitive
diagnosis was delayed by inconclusive complementary imaging. Clinical Case. A thirty-seven-year-old female presented with
an iliofemoral venous thrombosis of the right lower limb. The patient had presented with an episode of femoral-popliteal
vein thrombosis ﬁve months before and was currently under anticoagulation. Phlegmasia alba dolens installed progressively, as
thrombus rapidly extended to the inferior vena cava despite systemic thrombolysis and anticoagulation.Diagnostic imagingfailed
to identify the underlying aetiology of the deep vein thrombosis. The deﬁnitive diagnosis of primary venous leiomyosarcomawas
reached by a subcutaneous abdominal wall nodule biopsy. Conclusion. Primary venous leiomyosarcoma of the iliac vein is a rare
cause of deep vein thrombosis, which must be considered in young patients with recurrent or refractory to treatment deep vein
thrombosis.
1.Introduction
Deep vein thrombosis (DVT) is diagnosed in 56 to 122 per
100000 individuals each year [1] and gradually becomes
more frequent as age increases [2]. Withmultiple risk factors
recognised, including genetic and exogenous factors [3],
DVT’s pathogenesis is usually related to venous stasis (ob-
structive or nonobstructive), disruption of the vascular wall
or to hypercoagulable states [3].
Occult tumours may present as DVT. Among these, pri-
mary venous leiomyosarcoma remains a rare tumour, with
approximately 400 cases published [4] since its ﬁrst descrip-
tion in 1871 by Perl [5]. However, leiomyosarcoma is the
most frequent tumour of the venous system, arising in more
than half of the cases in the inferior vena cava (IVC) [6].
Tumours with a venous origin are generally malignant
and diﬃcult to diagnose [7] with up to one third of the
diagnosis reached post mortem [6].
A case of primary venous leiomyosarcoma of the right
iliac vein which presented as a recurrent DVT is reported.
2.ClinicalCase
A 37-year-old caucasian female presented with pain and
oedema of the right lower limb with three days of evolution.
Symptoms had started two days after a two-hour ﬂight.
Accompanying symptoms were nonquantiﬁed fever and
dysuria. The patient denied any loss of weight, anoraexia,
asthenia, abdominal or lumbar pain, or history of trauma of
the right lower limb.
About ﬁve months prior to this episode, the patient had
been diagnosed with a femoral-popliteal vein thrombosis in
the same lower limb and was started on anticoagulation with
warfarin, with a therapeutic international normalized ratio
(INR)goldof2-3.Diagnostictestingpriortoanticoagulation
revealed normal prothrombin time (PT) and activated par-
tial thromboplastin time (aPTT) values, and prothrombotic
conditions screening (including lupus anticoagulant, anti-
cardiolipin antibodies, antithrombin III, Protein C, Protein
S functional and antigenic assays, Leiden V factor, and
homocysteinemia) was negative.2 Case Reports in Medicine
Remaining medical history was notablefor depressive sy-
ndromeandallergicrhinitis. Alongwithwarfarin, thepatient
was medicated with mexazolam 1mgid, Daﬂon 500 (r)bid,
and ﬂuoxetine 20mgid. The patient was a mother of two
healthy children, agedthree and twelveyears, bornfrom nor-
mal full-term deliveries. A previous history of oral contra-
ceptives was found but had been suspended over threeyears.
Metrorrhagia or amenorrhea was denied. Smoking habits
of about one pack a day had ceased tenyears before the
beginning of the present illness.
In regard to family history, a heavy history of malignan-
cies was found, including a brother who died at age thirty-
nine of a pulmonary adenocarcinoma. Among the patient’s
uncles and grandparents, several cases of cancer (a gastric
cancer, a multiple myeloma, a cervical uterine cancer, and a
case of prostate cancer), type 2 diabetes mellitus, coronary
disease, and cerebrovascular disease were identiﬁed.
Presenting physical examination revealed a fever of
38.2◦C and a body mass index of30.3. Oedema was observed
involving the full extension of the right lower limb without
cyanosis. All pulses were palpable, symmetrical, and had
normal amplitude. Abdominal palpation did not reveal
the presence of masses or organomegalies. The remaining
physical examination did not identify any other pathological
ﬁnding.
A haemoglobin of 12.4g/dL,an INRof2.08 and an aPTT
of30.5 seconds were obtained in a laboratory workup. White
blood count and diﬀerential were normal, reactive C protein
was 0.74mg/dL. Microscopic urinary sediment examination
was positive for leucocytes.
Duplex and colour Doppler imaging of the lower limb
conﬁrmed a right venous iliofemoral thrombosis with exten-
sion to the ipsilateral great saphenous vein and abdominal
wall collaterals. Arterial examination was normal.
Initial approach coursed with suspension of oral anti-
coagulation and systemic thrombolysis with reteplase (rt-
PA) in a dose of 9mg/kg, (10% in a bolus during the
ﬁrst minute followed by a continuous perfusion during
one hour of the remaining) followed by a nonfractioned
heparin perfusion over 48hours. Warfarin was resumed, and
therapeutic low-molecular-weight-heparin was maintained
until achievement of an INR level of 2-3.
A contrast-enhanced computerized tomography scan
(CT-scan) of the abdomen and pelvis revealed extension of
right iliac vein thrombosis to the IVC and also noted an
“exuberantagglomerateofthrombosedvenouscollaterals”in
the right lower quadrant of the abdominal wall, according to
the report. No masses were mentioned.
Positive hemocultures were obtained for Serratia Mar-
cescens, sensitive to antibiotic therapy in course (Piperacilin
and tazobactam). Uroculture was negative.
Antinuclear autoantibodies (anti-Sm; anti-Ro/SSA; anti-
La/SSB; antitopoisomerase [Scl-70]; anticentromere and
anti-t-RNA-sintetase [Jo1]) and serologic tumour markers
(Carcinoembryonic antigen, Cancer antigen 125, Cancer
antigen 15.3, and Cancer antigen 19.9) were negative.
The patient was discharged after 19 days of hospital-
ization under oral anticoagulation with progressive symp-
tomatic relief.
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Figure 1: Abdominal and pelvic CT scan. A mass (arrow) was
described as an “agglomerate of venous structures” involving a
dilated right iliofemoral axis, but its tumor aetiology was not
recognised. A nodule is observed but was reported as “thrombosed
collateral circulation in the subcutaneous adipose plane of the ipsi-
lateral inferior quadrant of the abdominal wall” (∗). The deﬁnitive
diagnosis of primary venous leiomyosarcoma was obtained from a
biopsy of the nodule.
A month after discharge, the patient was readmitted with
a recurrence of pain and oedema of the right lower limb.
Despite oral anticoagulation, oedema hada extended to the
left lower limb, lumbar region, and abdominal wall (right
lower quadrant), and a painful ill-deﬁned subcutaneous
nodule with an approximate diameter of 4 centimetres was
now palpable in the same abdominal quadrant. Pulses were
not palpablein theright lowerlimbduetoextensive oedema,
butarterialduplexandcolourDopplerremainedunchanged.
A mild normocytic normochromic anaemia was now found
on laboratory workup although acute visible losses were not
identiﬁed.
An abdominal and pelvic contrast-enhanced CT scan
revealed thrombus progression to the suprahepatic IVC. The
presence of tumour was not reported although an increase
in maximum diameter of “the thrombosed collateral circula-
tion” of the pelvis and abdominal wall was noted (Figure 1).
An abdominal magnetic resonance (MRI) failed to further
clarify this ﬁnding.
Screening for warfarin resistance did not identify poly-
morphisms of CYP2C9 and VKORC1 genes. Other throm-
bogenic genetic polymorphisms were tested including: F5
(G1691A), FII (G20210A), MTHFR (C677T e A1298C), and
PAI-1 (4G/5G). An MTHFR C677T-CT variant of the gene
was identiﬁed.Althoughassociated with anincreased levelof
homocysteinemia in carriers, an allelic frequency of 41.68%
has been reported in our resident population [8].
The abdominal wall nodule biopsy revealed a pleomor-
phic leiomyosarcoma of vascular origin. Fusiform and mult-
inucleated cells predominated, with a high rate of atypical
mitotic ﬁgures (more than 50 per 10 ampliﬁed ﬁelds). This
nodule was positive for smooth cell immunohistochemicalCase Reports in Medicine 3
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Figure 2: Thoracic CT scan. Multiple micronodules are visualized
in peripheral topography, more numerous at the right lung, where
an 8mm nodule can be identiﬁed in the apical segment of the
inferior lobe, with topography and morphology suggestive of
metastases.
markers(calponin,desmin, HHF35,alfa-actin, smooth mus-
cle actin, and h-caldesmon) and was negative for epithelial
markers (keratin), neuronal markers (S100) hematopoietic
markers (CD34), oestrogen, or progesterone receptors.
A thoracic contrast-enhanced CT scan showed multiple
infracentimeric pulmonary metastases and thrombus pro-
gression had reached the right atrium (Figure 2).
Despite chemotherapy with doxorubicin and iphosph-
amide, the disease progressed fatally over a few weeks.
A postmortem was not felt of value by the attending
physicians, and thus was not performed.
3.Discussion
Leiomyosarcomas represent 10% to 15% of connective tissue
sarcomas, 45% of retroperitoneal tumours [9], and 0.5%
of sarcomas in adults [6]. A female gender preference has
been reported, with a 6 to 1 ratio between female and
male genders [10]. Primary venous leiomyosarcoma of the
IVC is more frequent in women in their sixth decade [11]
although reports of younger patients are found [12]. When
the primary site of involvement is the lower limb, no gender
preference is found [13].
Primary venous leiomyosarcomas arise from vascular
smooth-muscle cells [7] and growth pattern may progress
from intramural to endoluminal, extraluminal, or mixed
forms[11].Pathologicalclassiﬁcationfollowsretroperitoneal
leiomyosarcoma criteria based upon mitotic ﬁgures count
[14].
Approximately half of primary venous leiomyosarcomas
originate in the IVC [4]. Less frequently, great saphenous
vein (25%), femoral vein, internal jugular vein, and iliac vein
involvement has been reported [7].
Clinical presentation of primary venous leiomyosarco-
mas is frequently oligosymptomatic and insidious [14]g i v e n
their variable location allied to a slow growth rate, and its
diagnosis may result of an incidental ﬁnding. However, at
time of diagnosis, more than one half of the cases already
present with pulmonary metastases [13]. Acute venous
thrombosis is the most common presentationof the iliacpri-
mary venous leiomyosarcoma. Other symptoms may occur
due to compression of the iliac artery and pelvic organs.
Primary venous leiomyosarcomas are clinically divided into
nonocclusive,occlusiveorterminal[15].Otherfrequentclin-
ical presentations includeabdominal pain [16], consumptive
symptoms (loss ofweight, anorexia, or asthenia), fever, night
sweats, nausea, vomiting, and dyspnoea [17]. On physical
examination an abdominal mass may be detected. Other less
frequent presentations includehaematuria [18], a renal mass
[19], or a cardiac tumour [10].
Classically, the IVC is divided into 3 segments: seg-
ment I—the infrarenal IVC, segment III—proximal to the
suprahepatic veins, and segment II—between the renal and
suprahepatic veins [20]. Variable frequencies of segment
involvement are featured among the literature, one series
reporting segment I, II, and III involvement in 34%, 41,7%,
and 24,3% respectively [21].
Hematogenous spread commonly leads to secondary
deposits in the lung, liver, and brain in primary venous
leiomyosarcoma. In later stages, lymphatic pathways may be
involved in metastization [22].
Occult tumour screening is indicated in recurrent or
refractory to anticoagulation DVTs and may be considered
if testing for other “benign” hypercoagulable conditions is
inconclusive [23]. Diagnostic inaccuracy of complementary
imaging has been reported in the literature concerning
primary venousleiomyosarcoma [23] despite reports of high
diagnostic sensibility (78% and 95%) and speciﬁcity (96%
and 100%) of CT and MRI, respectively, for IVC thrombosis
[10].
Diﬀerential diagnosis includes retroperitoneal leiomyo-
sarcomas, intravenous leiomyomatosis, endometrial stromal
sarcoma, sarcomatoid renal cell carcinoma, angiosarcoma
[4], and hemangioendothelioma [24].
Some authors have reported a high incidence (21%) of
prior operated uterine tumours among patients with pri-
mary venousleiomyosarcoma oftheIVC, suggesting anasso-
ciation. However, diﬀerential can be established through
oestrogen and progesterone receptor testing [6].
Optimal treatment is yet tobeestablished duetoPrimary
Venous Leiomyosarcoma’s limiting low incidence and conse-
quent clinical experience [25]. However, an aggressive surgi-
cal approach assuring a free margin en bloc tumour resection
canbecurati v e[25]despitereported local recurrenceratesin
selected cases of 40 to 60% [10].
First-line chemotherapy with anthracycline derivates
[26] and radiotherapy have failed to demonstrate long-term
beneﬁt in survival [6].
Poor prognostic factors include IVC segment III involve-
ment, IVC occlusion, lower limb oedema, Budd-Chiari syn-
drome, intraluminal tumour growth [21], and diagnosis in4 Case Reports in Medicine
advanced stages [14]. Patients with primary venousleiomyo-
sarcoma have a mean survival of 3.5 years, and favourable
outcome relies greatly upon eligibility and achievement of
afreemarginresection[5].Comparativelytoothersarcomas,
primary venous leiomyosarcoma has a shorter metastases
free interval and survival [26].
4.Conclusion
In regard to DVT, diﬀerentialdiagnostic considerationsprior
to thrombolytic treatment and surgery should include tum-
ours, particularly if thrombolytic treatment proves ineﬀec-
tive.
In our patient, CT and MRI played a controversial role,
delaying the deﬁnitive diagnosis which was only achieved
by a biopsy. These imaging modalities were inconclusive at
an advanced stage of disease, and should any of these had
been performed upon initial clinical presentation, 5months
before the deﬁnitive diagnosis, an even lower diagnostic sen-
sibility might be expected.
Outcome depends upon tumour stage at diagnosis.
Therefore, achieving a histopathologic diagnosis, in the pres-
ence of high clinical suspicion, is of the outmost importance
in an eﬀort to obtain an early-staged deﬁnitive diagnosis.
In conclusion, primary venous leiomyosarcoma is a rare
cause of DVT and should be considered in recurrent or
refractory DVT in young patients.
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